Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

ILC1-like cells can independently cause alopecia areata.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.